Trial Profile
A Twelve Week, Randomized, Double Blind Parallel Group Study Of Two Doses Of Celecoxib Compared To Diclofenac In Patients With Ankylosing Spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Diclofenac
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Sponsors Pfizer
- 23 Mar 2016 New trial record
- 15 Mar 2016 Results published in the Journal of International Medical Research